Latest Stock Market News

SBI Q4 results: The bank posted an operating profit of Rs 31,286 crore in Q4FY25, marking an 8.83% increase over Rs 28,748 crore a year ago. However, the loan loss provisions surged 20.35% YoY to Rs 3,964 crore from Rs 3,294 crore in Q4FY24.

Despite geopolitical tensions, the markets closed the week positively, with the Nifty consolidating above its 200-DMA. Volatility increased, and the index saw a weekly gain. Caution is advised for the coming week, focusing on low-beta stocks and sectors poised for fresh moves, as the index faces key resistance levels. Relative Rotation Graphs indicate varied sector performance against the broader markets.

Despite geopolitical tensions, Nifty demonstrated resilience with a 3.46% gain in April, supported by FII inflows and strong domestic fundamentals. Analyst Sudeep Shah anticipates near-term consolidation between 23,800-24,600. Bank Nifty outperformed, hitting record highs, while Reliance showed strength. Defense stocks like Paras Defense and BEL are poised for further gains amid ongoing tensions.

SEBI Chairman Tuhin Kanta Pandey announced the regulator s commitment to resolving issues hindering the National Stock Exchange s IPO launch, focusing on governance, technology, clearing corporation matters, and ongoing litigations. NSE aims for transparency and accountability through the IPO, potentially exceeding Hyundai s record for the largest public issue, with an expected size of Rs 30,000 crore if 10% equity is sold.

Rate this item

(1 Vote)

Corona Remedies, an Indian pharmaceutical company, has filed preliminary documents with SEBI to launch an Rs 800-crore IPO. The IPO consists entirely of an offer for sale by promoters and existing investors like Sepia Investments, Anchor Partners and Sage Investment Trust. The company focuses on developing, manufacturing, and marketing pharmaceutical formulations across various therapeutic areas, including women s healthcare and cardio-diabeto.

Despite the RBI s 50 bps repo rate cut and liquidity infusion, a significant portion of borrowers haven t benefited due to reliance on MCLR-linked loans. MCLR remained unchanged at 9% in April, particularly affecting public sector borrowers. Banks deposit costs and competition for funds are hindering faster transmission of rate cuts, impacting net interest margins.

High gold prices significantly impacted Akshaya Tritiya sales, with volume declining by an estimated 30% nationwide. While overall gold sales volume decreased, value increased by 15-20% due to soaring prices, reaching ₹98,469 per 10 grams with GST. South India showed stronger demand, particularly for plain gold and diamond jewellery, contrasting with muted demand in other regions.

Panel to run IndusInd Bank till new CEO logs in

Updated at : 2025-05-01 20:45:01

Rate this item

(1 Vote)

Following CEO Sumant Kathpalia s resignation amid derivatives portfolio discrepancies, the RBI has approved IndusInd Bank s interim "committee of executives," including Soumitra Sen and Anil Rao, to manage daily operations. This committee will function under board oversight until a new CEO is appointed or for a maximum of three months.

Bank lending growth slows to 12% in FY25

Updated at : 2025-05-01 20:45:01

Rate this item

(1 Vote)

Credit demand at mainstream lenders slowed to 12% in FY25, down from 16% the previous year, influenced by regulatory curbs on retail and unsecured lending. While most sectors experienced a slowdown, loans to industry remained stable. Notably, lending against gold surged due to rising prices, and renewable energy saw significant growth.

Warning! Information Posting in this website is only for educational purpose. We are not responsible for losses incurred in Trading based on this information.